About 8 results found for searched term "91-16-7" (0.061 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3382 | Terbinafine | Squalene epoxidase |
| Terbinafine is used to treat infections caused by a fungus. It works by killing the fungus or preventing its growth. | ||
| M9646 | Decoglurant | GluR |
| RG-1578; RO4995819 | ||
| Decoglurant (also known as RO4995819) is a negative allosteric modulator of the mGlu2 and mGlu3 receptors. | ||
| M14174 | BMS-582949 hydrochloride | p38 MAPK |
| BMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory disease. | ||
| M20832 | ML-SI3 | TRP Channel |
| ML-SI3 is a potent TRPML channel inhibitor with IC50s of 4.7 µM and 1.7 µM for TRPML1 and TRPML2, respectively. | ||
| M20841 | Gemigliptin | Dipeptidyl Peptidase |
| Zemiglo, LC15-0444 | ||
| Gemigliptin (Zemiglo, LC15-0444) is a potent, selective and long-acting dipeptidyl peptidase 4 (DPP 4) inhibitor with a Ki of 7.25 nM. Gemigliptin shows at least >23,000-fold selectivity for DPP-4 over various proteases and peptidases, including DPP-8, DPP-9, and fibroblast activation protein (FAP)-α. | ||
| M25143 | Tagitanlimab | PD-1/PD-L1 |
| HBM-9167; KL-A167 | ||
| Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC). | ||
| M43861 | 4-Piperidinecarboxylic acid, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]-, 1,1-dimethylethyl ester | Ligand for E3 Ligase |
| 4-Piperidinecarboxylic acid, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]-, 1,1-dimethylethyl ester | ||
| M44675 | 1,2-Dimethoxybenzene | Others |
| 1,2-Dimethoxybenzene is an naturally occurring insect attractant. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
